AHCPR MAMMOGRAPHY GUIDE INCLUSION IN MQSA REGS WILL BE CONSIDERED BY FDA
This article was originally published in The Gray Sheet
Executive Summary
AHCPR MAMMOGRAPHY GUIDE INCLUSION IN MQSA REGS WILL BE CONSIDERED BY FDA, Commissioner David Kessler said at an Oct. 19 press conference announcing release of the clinical practice guideline. Kessler noted that eight of the 15 Agency for Health Care Policy and Research panelists who wrote the guidelines also sit on the agency Mammography Quality Advisory Committee.